Recommendation of the President – Daraprim (pyrimethamine)

On 1 August 2024, the President of the Agency for Health Technology Assessment and Tariff System issued  recommendation No. 81/2024 on the evaluation of the medicinal product Daraprim (pyrimethamine) for the indications congenital toxoplasmosis, ocular toxoplasmosis, central nervous system toxoplasmosis in the course of HIV infection

Publication in Public Information Bulletin (BIP) >>